2023-04-05-accounts - H And M Castang Charitable Trust

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

FOR THEYEARENDEDsTH A	PRIL 20	23	23
		UnrestrictedFunds
	Notes	Income Fund EE	Capital Fund	Restricted Fund E	Total 2fJ23 E	Total 2022 f
Incomeandendowmentsfrom:
Investments
Dividends received onequities Interestreceivedon other Investments	L7 19	53A2L 9,996			s3,42L 9,996	51,033 9,478
Interestreceivedonfixedinterest
stocks Stockbrokers accountinterest	18	13,163 351			13,163 351	12,631 0
Totalincome		76,93L		o	76,931	73,082
Expenditureon: Raising funds	6		LO,73l		to,73t	15,286
Charitable activities	2	64,672			64,672	43,098
Total expenditure		64,672	LO,73L	o	75,4O3	58,384
Netincome/(expenditure)		L2t259	(10,731)	0	1,528	74,698
Transfer between funds					o	0
		L2t259	(LO173L)	o	1,528	14,698
Gains/(losses)on investmentassets Unrealised t7-L9 Realised L7-Lg			(85,91O) (6,011)		(85,91O) (6,O11)	248,944 4,772
		o	(91,921)	o	(91,921)	253,656
NetMovementInFunds		L2,259	(102,652)	o	(90,393)	268,354
ReconciliationofFunds
TotalFundsbrought forward					1,982,031	7,773,677
TotalFundscarriedforward		269t823		,576,OOL	45,8L4	1,891,639

	Notes	2lJ23
		E	E	f	f
Fixed assets
Investments:
Equities	t7		L,253t639		1,349,559
Fixed income stocks	18		L94,979		270,854
Other investments	19		372,434		381,298
			1,821,O52		1,941,711
Currentassets
Debtors	11	o		0
Cashatbank andwithstockbrokers		72,883		47,976
Total Currentassets		72,883		41,916
Liabilities
Creditors: Amounts falling duewithinone year	t2	2,297		7,596
NetCurrentassets			7Ot5l'6		40,320
Net assets			1,891,638		1,982,037
Thefunds of the charity:	13
Unrestricted funds:
Capitalfund			tt576,OOL		1,678,653
Incomefund			269,823		257,564
Restricted fund			45,814		45,814
Total charity funds			1,891,638		1,982,037

	zfJ23	2022
2.CharitableActivities	E	E
Researchprojects	57,5O4	37,548
Othercosts	5,236	3,954
Governance costs	L,932	7,596
	64,672	43,098

OTES TO THEACCOUNTS OR THEYEAR ENDEDsTH	(CONTINUED) APRIL 2023
		2lJ23	2022
		E	€
ResearchProjects
NIHR CastangFoundationAdvanced Fellowship Award
DrAlexandra Hendry, University of Oxford-Refining, testing and targeting
an interventiontosupporttheearly developmentofExecutiveFunctions amongst infantsatelevated likelihood of autism and/orADHD		42,600	31,092
		42,600	31,092
BACDFundingAward-RAISE	ResearchingAllied Health inSchoolsand
Education
NewcastleUniversity	Researchstaffand
	runningcosts	0	0
		o	o
IanCrockerStudy-A Heme-Binding Agent forthePrevention ofFetal
Vascular Compromise
ManchesterUniversity		6t27L	0
		6,27L	0
Supportcosts		81533	6,456
		57,504	37,548

		2023	2022
		E	f
5,	Supportcosts
	Trustees'expenditure:
	Researchintoprojects beingconsidered
	by the Trustees and monitoring those
	supported by the charity Raisingfunds	8,633 lo,73L	6,456 75,286
	Governance costs	1,932	1,596
		2Lt296	23,338
	Allocatedasfollows:
	Grants and research projects	9,633	6,456
	Raisingfunds	1o,731	15,286
	Governance costs	L,932	1,596
		2L,296	23,338

	charges are attributabletosupportcostswith thebalanceattr administration.	ibutable tomanagementand
6.	Raisingfunds
	Investmentmanagementcosts:
	Stockbroker'snominee fees	8,321	73,342
	Administrativefees	2ALO	7,944
		LO,73L	15,286
7	Othercosts
	Bankcharges and interest	L2	30
	Printing, stationeryandwebsitecosts	388	120
	Management and administrativefees	4,836	3,804
		5,236	3,954
8.	Governance costs
	Accountancycharges	996	972
	Independent examiner'scharges	936	624
		L,932	1,596

FOR THEYEARENDEDsTH APR	IL 2023
		Fixed
		Income	Other	Total	Total
10.Investments Quotedinvestments	Equities E	Stocks E	Investments E	zlJ23 E	2022 f
(see notes 17,18&19) Market valueat6thApril2O22	1r3491559	10, 2 54	381,298	lt94l,7lL	1,693,943
Additions during the year Disposalsduring the year	6O,OO5 (94t7s4)	o o	o o	6O,OO5 (94t754)	88,461 (89,637)
Net unrealised investment gains/(losses)	(6Ll7L)	(15,87s)	(8,864)	(8s,910)	248,944
Market valueat5th April2023	1,253,639	L94,979	372,434	t,82l,O52	7,941,777
Historical costasat5t
April2O23	853,859	206,481	287,039	1,347t378	7,320,167

Statement of fun	ds
	Balanceat 06.o4.2022	Incoming Resources	Resources Expended	Netgains/ (losses)	Transfers	Balanceat o5.04.2023
	E	E	E		E	E
Unrestricted funds
Income fund
General CapitalFund	257,564 1,678,653	76,93L o	(64,672) (ro,73L)	o (91,921)	o o	269,823 1,576,0O1
	1,936,217	76t93L	(75,403)	(91,921)	o	L,845,824
Restricted funds
BACDfund	4s$L4	o	o	o	o	45t8L4
	45,814		o	o	o	45,814
Total funds	lrgg2r031	76,93t	(75,403)	(91,92L)	o	1,891,638


FutureCommitments			Future
	Total	Commitment
	Cost		at5.4.23
	E		E
TheTrusteeshaveagreedtofundthefollowing projects:
a.BACD	175,OOO		175,OOO
b.BACD(Restricted)	lSo,ooo		45,814
c.UniversityofManchester- IanCrockerStudy	165,655		52,559
d.NIHRCastang Foundation AdvancedFellowship Award	190,1O1		116,408
			389,781

	UnrestrictedFunds	UnrestrictedFunds
	Income Fund EE	Capital Fund	Restricted Funds E	Total funds 2lJ23 E	Total funds 2022 E
Fixedasset investments	245,O51	L,576tOOt	o	I,82I,O52	7,941,771
Currentassets Creditors	27,lJ69 (2t297)	o o	45,814 o	72,883 (2,297)	47,916 (1,596)
	269,823	l,576,0()1	45,8L4	1,891,638	1,982,O37

Comparative StatementofFinancialActivi	ties
	Unrestricted	Funds
	Income Fund EC	Capital Fund	Restricted Fund E	Total zlJ22 C
Incomeandendowmentsfrom:
Investments
Dividends received on equities	51,033			51,033
Interestreceived on other
Investments	9,479			9,418
Interestreceivedonfixedinterest
stocks	72,631			72,637
Totalincome	73,082	0	0	73,082
Expenditureon:
Raisingfunds		15,286		15,286
Charitable activities	43,098			43,098
Total expenditure	43,098	75,286	0	58,384
Net income/(expenditure)	29,984	(15,286)	0	14,698
Transfer between funds				0
	29,984	(15,286)	0	14,698
Gains/(losses)oninvestmentassets
Unrealised		248,944		248,944
Realised		4,772		4,772
	0	253,656	o	253,656
NetMovementfnFunds			0	268,354
ReconciliationofFunds TotalFundsbrought forward	224580	1,440,283	45,874	7t713,677
TotalFundscarriedforward	257,564	7,678,653	45,874	7,992,037

Investments-Equities
Heldwithin theU,K.	At 6thApril2022 Market Number Value E		Acquisitions Number Cost E		Sales NumberProceeds E			Realised Gains/ (Losses) E	Unrealised Gains,/ (Losses) €	At 5thApril2023 Market Number Value E		Historical Cost E	Date	Dividend Received f
AstraZeneca Ordinary25p Shares	1,OOO	1O3,340		23.O8.2022		3OO	3?,720	(2t7LA)	L4,256	7lJlJ	41,158	21,L97	sep lvlar	764.OO 1,139.60
BAESystems Ordlnary2.5pShares	8,5OO	62,968							zL,6(J7	a,5oo	a4,s7s	37,744	lun Nov	1,292,00 a84.OO
British American Tobacco Ord 25p shares	1,470	6(J,373							(7,e19)	\47,J	52,454	5O,235	May Aug	1,01a.22 1,O18.22
													Nov	r,018,22
													Feb	\oLa.22
BP Ordinary 0.25US$ Shares	12,OO0	45'94A							14,096	12,OO0	64,044	5',597	Jun sep	522,67 62().21
													Dec	592,a2
													Mar	566.O8
Diageo ordinary 28totTrorpShares	2,3OO	91,52a		23.O4.2022		300	Lt492	(446)	(6,21O)	2,OOO	73,34O	12,84O	Apr Oct	675,2A 936,40
Digital9 Infrastructure OrdNPV	34,o95	42,4OO							(t6,s72)	38,O95	2s,82A	4').275	Jun sep	s71,43 571,43
													Dec	571,43
Foresight Solar FundLtd NPV	4O,00o	44t4AO							(32O)	40,OO0	44,16lJ	39,949	lvlar lvlay Au9	57t,43 694,00 7L2.OO
													Nov	7L2,OO
													Feb	7t2,OO
GSK Ordinary25pShares	5,OOO	a5,190	(1s,469) (Demerger of	Haleon Group	1,OOO 1:1)		o	(1,56e)	(8,664)	4,OOO	s9,4a8	63,143	Apr Jul Oct Jan	1,15O.00 700.oo 650.OO 550.O0
Haleon Group Ordinary €1.25shares ImpactHealthcare Reit Ordinary1p shares	3a,ooo	46,056	5,OOO L5,46902.Oa.2O22 (Demerger outof GSK1:1)		5,OOO		15,150	(319)	(10,716)	38,OOO	3s,34O	39,s99	May sep	521,30 621,30
													Nov	621,30
													Feb	621,30
JPMorqan Global CoreRealAssets OrdNPV	4O,O0O	37,600							(3,360)	4O,OO0	34,24lJ	40,275	May Au9	400.oo 400,oo
													Nov	400,00
													Apr	344.45
Land Securities Ordinary 10.6666666pShares	4,570	35,a65							(7.668)	457lJ	2A,t97	24,094	Feb Jan Jul	420.00 411,30 594,10
													Oct	393.O2
Carriedforuard		655,748					60,362	(s,Os2)	(7,47lJ)		542,464	420,992		26,227,73

Investments'Equities(Continue	d)
Heldwithin theU.K, Broughtforuard	At 6th April Number	2022 Market Value E 655,748	Acquisitions Number Cost E o		Sales NumberProceeds E 6O,362	Realised Gains,/ (Losses) E (s,os2)	Unrealised Gains/ (Losses) E (7,47O)	At sth April2023 Market Number Value EE 582,864		Historical Cost 420'992	Date	Dividend Received E 26,227.73
Legal & General Ordinary272p Shares	24,OOO	65,44A					(9,O96)	24,OOO	56,352	34,67O	Jun sep	3,184.aO 1,3O5.6O
M.P. Evans Group Ordinary 10pShares			05.01.20233,600	29,454			2.226	3,6OO	31,680	29,454
PRSReit (The) Ordinary1p shares	29,2.J5	31,a33					(8,148)	29,2O5	23,585	29,42.6	lvlay Auq	292.O5 292,O5
											Nov	292,05
											lvlar	292.O3
RELXGroup Ordinary 14 51/116pShares	4,6OO	L12,47O			1,200 28,381	(9s9)	6,120	3,40O	89,250	22,OOt	Jun sep	1,533.OO 722.20
SDCLEnergy Efficiency Income Trust Ordianry1pshares	40,OOO	4A,4AO					(14,16O)	4O,0OO	34,3zlJ	4lJ,677	Jun sep	552.OO 600,oo
											Dec	600.oo
											Mar	600.oo
Shell OrdinaryEuro0.7	3,OOO	53,530					7,26.)	3.OOO	7O,a9O	39,095	Jun sep Dec	600.30 647.1O 514,30
											Mar	723.30
Supermarket IncomeREIT Ordinary1p Shares	35,O0O	46.aO0					(16,344)	36,000	30,456	37,161	May Aug	534.60 534.60
											NoV	540.OO
											Feb	540.OO
Unilever Ordinary3l/npShares	L,7OO	6O,L2t					t2,7A4	\7OO	72,9lJ5	t5,457	Jun sep	610.30 6L7.6L
											Dec	632.74
											Mar	648.O4
Vodafone Ordinary US90.2095238 shares	29,OOO	36,389					(10,449)	Z9,0OO	2',940	45233	Aug Feb	I,O97,69 t,L48,17
Held OutsidetheU.K.
Roche Holdings AG
Genusscheine NPV (NES)	300	94,4O5					(23,616)	300	7L,tA9	to,374	lvlar	1,514,49
Samarang Asset ManaqementS.A. Asian ProsperityA1	L43	38,460					(762)	L43	t7.69a	41,O42	Dec	1,684,54
Schrcder Oriental Ordinary1p Shares	35,O0O	95,375					(s,775)	35,OOO	89,6O0	t7,726	May Aug Nov	65s.OO 700.oo 1,96O.OO
UniversalMusicGroup Euro10 shares			(2r.7O.2O22)l.aso	3o,ss1			6,259	1,a5O	36,a10	3O,551	Feb	700.oo
	1,349,559			6O,OO5	88,743	(6,011)	(6'-,171'		1,253,639	853,a59		s3A2O,7L

18, Investments -FixedIncome	stocks
	At 6th April Number EE	2022 Market value	Acquisitions Number Cost EE		Sales NumberProceeds EE		Realised Gains,/ (Losses) €	lJnrealised cains/ (Losses) E	At sth April2023 Market Number Value EEE		Historical Cost	Date	Income R*eived E
CGPortfiolioFund The DollarFund CLS'D'	3O0	5L.942						(1,9s9)	3Oo	49,9A3	48,1a6	Nov	508.1S
CQS NewCityHighYield FundLtd OrdinaryShares IOO,OOO		53,7OO						(s,o50)	loo,ooo	48,650	52,388	tvtay Au9	1,OOO.0O 1,48O.OO
												Nov	1,OOO.OO
												Feb	1,OOO,OO
GCPlnfrastructureInvestments OrdinaryC€0.01	Ltd 15,291	L7.LA7						(3,960)	15,291	'-3,227	16,O95	lun sep Dec	267,s9 267.59 267,59
												lvlar	267.59
InvescoBondIncomePlus OrdinaryNPV	3O,OOO	5:Jt175						(4,OsO)3O.OOO		49,L25	s5,L47	14ay Aug	a25.OO 825.OO
												Nov	462.50
Held OutsidetheU.K.												Feb	862.50
Biopharma Credit OrdLJSDo.01 Shares	44.OOO	34,a5O						(855)	44,OOO	33,994	34,665	May sep	511.63 649.15
												Nov	2,36a.25
		2totaB4		o		o		(1s,87s)		t94t979	2O6'4AL		13,L52.54
19. Investments - Other
Heldwithin theU.K.	At 6th April Number	2022 Market Value E	Acquisitions Number Cost E		Sales NumberProceeds €		Realised Gains/ (Losses) 2	Unrealised Gains/ (Losses) E	E Number At5thApril2023 Market Value		E Historical Cost	Date	Dividend Received €
Bny l4ellonN4anagersLtd Real Return	39,OO0	44,6s5						(2,ss 1)	39,OOO	42tLO4	39,935	sep Feb	421,50 490,20
Charities PropertyFund IncomeShares	50,ooo	54,545						(s,39s)	5O,OOO	63,190	60,120	May Aug	717,71 617,75
												Nov	523.45
												Feb	565.55
Ruffer InvestmentCompany Red PtgPref.0001pShares	24,OOO	74,O4O						L2O	24,OOO	74tt6o	3O,814	Oct Mar	300.oo 324.OO
Held OutsidetheU.K.
LinkFundSolutionsLtd Trojan Global lncomeOInc	7a,ooo	Lo5,2t4						(6,326)	7a,OOO	9a,aaa	49,342	Jun sep	937.25 754.34
												Jan	843.65
												Mar	595.OA
VeritasFund Global Equity IncomeSterlin(	4OO	88,804						5,288	400	94,O92	66,828	Apr Oct	861.52 1,842.6a
		341,298		o		o		(8,864)		372,434	2A7,O39		9r995.O8